EUVIMEDEUVIMED entdecken
VergleichsstudieNetzwerk-MetaanalyseSystematische ÜbersichtOpen Access · CC BY-NC-ND 4.0

Comparing the efficacy and safety of medications to prevent nonsteroidal anti-inflammatory drug-induced ulcers in high-risk patients: A network meta-analysis

Xu Huang, Qingying Fang, Liwei Zhou, Chenxi Gong, Dongmei Pei

Digestive and Liver Disease · 2026-02 · 58 (2) · 197-205

DOI: 10.1016/j.dld.2025.11.012 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Digestive and Liver Disease, 2026-02. Verfasst von Xu Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Management, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, China. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Non-Steroidal, Anti-Ulcer Agents, Peptic Ulcer, Proton Pump Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The optimal strategy for preventing nonsteroidal anti-inflammatory drug-induced peptic ulcers in patients with prior peptic ulcers remains uncertain. We performed a systematic review and network meta-analysis of 22 randomized controlled trials (7,768 patients) on nonsteroidal anti-inflammatory drug users with a documented ulcer history to compare the efficacy and safety of medications for the prevention of these ulcers. The eligible interventions included proton pump inhibitors, potassium-competitive acid blockers, cyclooxygenase-2 inhibitors, prostaglandin analogs, histamine-2 receptor antagonists, and gastric mucosal protective agents. The primary outcomes were ulcer recurrence and bleeding. The safety outcomes included treatment-emergent adverse events and discontinuation owing to adverse events. Random-effects network models estimated the relative and absolute risks, numbers needed to treat, and rankings. Compared with placebo, cyclooxygenase-2 inhibitor plus proton pump inhibitor, potassium-competitive acid blocker, cyclooxygenase-2 inhibitor alone, and proton pump inhibitor monotherapy markedly reduced ulcer recurrence (numbers needed to treat = 5-6). Similar patterns were observed for bleeding prevention. Prostaglandin analogs increased adverse events and discontinuations. Proton pump inhibitor monotherapy remains the most evidence-based first-line strategy for these patients. Cyclooxygenase-2 inhibitor plus proton pump inhibitors or potassium-competitive acid blockers may provide additional benefits in very high-risk patients, but safety and cost considerations warrant caution.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Inflammatory Agents, Non-SteroidalAnti-Ulcer AgentsPeptic UlcerProton Pump InhibitorsHumansCyclooxygenase 2 InhibitorsHistamine H2 AntagonistsRandomized Controlled Trials as TopicRecurrence

Stichwörter der Autor:innen

Bleeding preventionProton pump inhibitorUlcer recurrence

Substanzen

Anti-Inflammatory Agents, Non-SteroidalAnti-Ulcer AgentsCyclooxygenase 2 InhibitorsHistamine H2 AntagonistsProton Pump Inhibitors

Autor:innen und Institutionen

  • Department of Health Management, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, China.
  • Department of Rheumatology and Immunology, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Department of Health Management, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, China. Electronic address: peidm1111@hotmail.com.

Zitieren

APA

Huang, X., Fang, Q., Zhou, L., Gong, C., & Pei, D. (2026). Comparing the efficacy and safety of medications to prevent nonsteroidal anti-inflammatory drug-induced ulcers in high-risk patients: A network meta-analysis. Digestive and Liver Disease, 58(2), 197-205. https://doi.org/10.1016/j.dld.2025.11.012

Vancouver

Huang X, Fang Q, Zhou L, Gong C, Pei D. Comparing the efficacy and safety of medications to prevent nonsteroidal anti-inflammatory drug-induced ulcers in high-risk patients: A network meta-analysis. Digestive and Liver Disease. 2026;58(2):197-205. doi:10.1016/j.dld.2025.11.012

BibTeX
@article{Huang2026,
  author = {Huang, Xu and Fang, Qingying and Zhou, Liwei and Gong, Chenxi and Pei, Dongmei},
  title = {Comparing the efficacy and safety of medications to prevent nonsteroidal anti-inflammatory drug-induced ulcers in high-risk patients: A network meta-analysis},
  journal = {Digestive and Liver Disease},
  year = {2026},
  volume = {58},
  number = {2},
  pages = {197--205},
  doi = {10.1016/j.dld.2025.11.012}
}
Kostenlos starten →